Transcutaneous Pulsed Radiofrequency Targeting the Tibial Nerve Versus Radial Extracorporeal Shock Wave Therapy for Painful Calcaneal Spur: a Randomized Controlled Trial
Heel pain is a common musculoskeletal complaint that can substantially impair daily activities and reduce patients' quality of life. Calcaneal spurs are frequently associated with plantar heel pain, although the presence of a spur does not necessarily indicate that it is the direct source of symptoms. Treatment is generally conservative and may include activity modification, stretching exercises, orthoses, analgesics, and physical therapy modalities. However, some patients continue to experience symptoms despite these interventions.
Extracorporeal shock wave therapy (ESWT) is an established non-invasive treatment option for persistent plantar heel pain and plantar fasciopathy. It delivers acoustic pressure waves to the target tissue and is thought to exert its therapeutic effects through mechanotransduction, vascular responses, tissue remodeling, and modulation of nociceptive signaling.
Pulsed radiofrequency (PRF) is a neuromodulatory technique that delivers intermittent radiofrequency energy while limiting thermal tissue damage. Its proposed mechanisms include modulation of nociceptive transmission and neural signaling rather than intentional nerve destruction. Transcutaneous pulsed radiofrequency (TCPRF) provides a non-invasive approach by delivering radiofrequency energy through surface electrodes, without the need for needle insertion.
Although radiofrequency-based interventions and ESWT have been investigated separately in patients with painful calcaneal spurs and plantar heel pain, clinical evidence regarding TCPRF targeting the posterior tibial nerve remains limited. This randomized controlled trial compared the effects of TCPRF applied over the posterior tibial nerve with radial ESWT in patients with symptomatic calcaneal spurs. Pain intensity, foot-related function, and analgesic consumption were evaluated over a three-month follow-up period.
연구 개요
상태
상태
정황
정황
개입 / 치료
개입 / 치료
상세 설명
This prospective, single-center, randomized controlled trial was conducted between September 2024 and April 2025 in the Pain Medicine and Physical Medicine and Rehabilitation departments of the University of Health Sciences Istanbul Kanuni Sultan Suleyman Training and Research Hospital. A total of 55 patients aged 18-65 years with symptomatic, radiologically confirmed calcaneal spurs who had not responded adequately to conservative treatment were enrolled.
Following confirmation of eligibility and provision of written informed consent, participants were assigned to one of two treatment groups using a computer-generated randomization sequence: the TCPRF group (n = 29) or the radial ESWT group (n = 26). The sample size calculation was performed using G*Power version 3.1.9.4, with a two-sided significance level of 0.05, statistical power of 90%, and an effect size of 0.85 based on pain intensity data from a previous randomized trial of TCPRF. The calculated minimum sample sizes were 28 participants for the TCPRF group and 24 for the ESWT group.
In the TCPRF group, treatment was administered by an experienced pain medicine specialist under standard monitoring, including non-invasive blood pressure measurement, pulse oximetry, and electrocardiography. Participants were placed in the supine position. A 45 × 98 mm transcutaneous electrode (FIAB SPA, Italy) was positioned at the ankle, posterior to the medial malleolus, along the course of the posterior tibial nerve and adjacent to the posterior tibial artery, which was identified by palpation. TCPRF was delivered at 80 V, 2 Hz, and a pulse duration of 20 ms for 8 minutes. The treatment was administered once weekly for a total of three sessions.
In the ESWT group, radial extracorporeal shock wave therapy was delivered using an electro-pneumatic device (Vibrolith Orto®). All sessions were administered by the same physiotherapist under the supervision of a physical medicine and rehabilitation specialist with at least 10 years of experience in ESWT prescription. Participants were positioned prone, and radial shock waves were applied to the calcaneal spur region using the following parameters: 10 Hz, 2,000 impulses, and 2.5 bar. Treatment was administered once weekly for a total of three sessions.
Participants in both groups received standardized instructions regarding a home exercise program that included foot and plantar fascia stretching exercises. Paracetamol was permitted as the only rescue analgesic during the follow-up period; the use of other analgesics, including non-steroidal anti-inflammatory drugs, was discouraged.
Treatment outcomes were assessed by an independent pain medicine specialist who was blinded to treatment allocation. Demographic and clinical data, including age, sex, body mass index, symptom duration, comorbidities, concomitant medical treatments, and the treated side, were recorded at baseline. Pain intensity was assessed using the Visual Analogue Scale (VAS), a 10-cm scale ranging from 0 (no pain) to 10 (the worst pain imaginable). Participants were asked to indicate their average heel pain during the preceding week. Foot-related function was evaluated using the Foot Function Index (FFI), a validated 23-item questionnaire comprising three domains: pain, disability, and activity limitation. Higher FFI scores indicate greater functional impairment. Mean daily paracetamol consumption was also recorded in milligrams per day.
VAS scores, FFI scores, and daily paracetamol consumption were evaluated at baseline (T0), one month (T1), and three months (T3) after treatment. The FFI was prespecified as the primary outcome, while VAS pain scores and mean daily paracetamol consumption were considered secondary outcomes.
연구 유형
연구 유형
등록 (실제)
등록
단계
단계
- 해당 없음
연락처 및 위치
연구 장소
-
-
-
Istanbul, 터키 (Türkiye), 34000
- Kanuni Sultan Süleyman Training and Research Hospital
-
-
참여기준
자격 기준
자격 기준
공부할 수 있는 나이
건강한 자원 봉사자를 받아들입니다
연구 대상 성별
설명
Inclusion Criteria
Patients aged 18-65 years.
Patients diagnosed with calcaneal spur based on medical history, clinical examination, and radiological findings, who had not responded adequately to conservative treatment.
Patients who provided written informed consent to participate in the study.
Exclusion Criteria
Patients who had undergone any interventional procedure for calcaneal spur within the preceding 6 months.
Patients with morbid obesity (body mass index > 35 kg/m²).
Patients with advanced decompensated heart failure or an implanted cardiac pacemaker.
Patients with a known allergy to transcutaneous electrodes or pads.
Patients with skin infection at the ESWT application site or the transcutaneous electrode placement site.
Patients with metal implants.
Patients with circulatory disorders or skin lesions in the treatment area.
Patients unable to communicate adequately or maintain the required treatment position.
Patients with bleeding disorders.
Patients with active psychosis, progressive neurological deficits, or neuromuscular disorders.
Pregnant women.
공부 계획
연구는 어떻게 설계됩니까?
디자인 세부사항
- 주 목적: 치료
- 할당: 무작위
- 중재 모델: 병렬 할당
- 마스킹: 없음(오픈 라벨)
팔의 수
무기와 개입
참가자 그룹 / 팔참가자 그룹 / 팔 |
개입 / 치료개입 / 치료 |
|---|---|
|
다른: 발뒤꿈치돌기의 후경골신경의 신경조절(Epin Calcanei)
|
Instead of invasive application of PRF directly to the lesion area or nerve, transcutaneous pulsed radiofrequency (TCPRF) is applied noninvasively. |
|
다른: 체외충격파치료(ESWT)
|
A shock wave is created together with sound and pressure waves. Changes at the cellular level with the shock wave include increased collagen production, increased blood flow in the applied area, acceleration of wound healing and cellular proliferation. |
연구는 무엇을 측정합니까?
주요 결과 측정
주요 결과 측정
결과 측정 |
기간 |
|---|---|
|
Visual Analogue Scale
기간: three months
|
three months
|
|
Foot Function Index
기간: three months
|
three months
|
공동 작업자 및 조사자
수사관
수사관
- 수석 연구원: halil ibrahim altun, specialist, Kanuni Sultan Süleyman Training and Research Hospital
연구 기록 날짜
연구 주요 날짜
연구 시작 (실제)
연구 시작
기본 완료 (실제)
기본 완료
연구 완료 (실제)
연구 완료
연구 등록 날짜
최초 제출
최초 제출
QC 기준을 충족하는 최초 제출
QC 기준을 충족하는 최초 제출
처음 게시됨 (실제)
처음 게시됨
연구 기록 업데이트
마지막 업데이트 게시됨 (실제)
마지막 업데이트 게시됨
QC 기준을 충족하는 마지막 업데이트 제출
QC 기준을 충족하는 마지막 업데이트 제출
마지막으로 확인됨
마지막으로 확인됨
추가 정보
이 연구와 관련된 용어
기타 연구 ID 번호
기타 연구 ID 번호
- heelspur
개별 참가자 데이터(IPD) 계획
개별 참가자 데이터(IPD)를 공유할 계획입니까?
약물 및 장치 정보, 연구 문서
미국 FDA 규제 의약품 연구
미국 FDA 규제 기기 제품 연구
이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .